Trading Lives or Changing Human Nature: The Strange Dilemma of Embryo-Based Regenerative Medicine
It is, perhaps, the most important scientific advance in the past one hundred years, and its potential is not even close to realization. It is the most controversial technology imaginable, an improbable combination of the abortion, cloning, fetal tissue, transplantation, gene therapy, animal rights and regenerative medical technology debates, raising worries about women in research, sex, the regulation of in vitro fertilization (IVF) clinics, the danger of changing the human germ line, and the war against aging. Before it is developed, some of the most powerful politicians on earth will find themselves forced to modify deeply entrenched views, and a few dozen scientists will become billionaires through patents on bits and parts of embryos.
KeywordsEmbryonic Stem Cell Assisted Reproductive Technology Moral Status Human Embryo Preimplantation Genetic Diagnosis
Unable to display preview. Download preview PDF.
- Bush, President G.W. (2001). ‘Address to the Nation on Stem Cell Research,’ Vanderbilt Television News Archives, August 9, 2001, [Online] Available: <tvnews.vanderbilt.edu>. Also available at: <http://www.whitehouse.gov/news/releases/2001/08/20010809-2.html>.
- Chapman, A.R., Frankel, M.S. & Garfinkel, M.S. (1999). Stem Cell Research and Applications: Monitoring the Frontiers of Biomedical Research, AAAS/ICS Report.Google Scholar
- Edwards, R.G. (1996). ‘Human Conception In Vitro 1995, A Summing Up,’ Human Reproduction, 11(suppl. l), 199–211.Google Scholar
- Edwards, R.G. & Steptoe, P.C. (1974). ‘Control of Human Ovulation, Fertilization and Implantation,’ Proceedings of the Royal Society Medicine, 67(9), 932–936.Google Scholar
- Farley, M. (2001). ‘Roman Catholic Views on Research Involving Human Embryonic Stem Cells,’ In S. Holland, S. Lebacqz and L. Zoloth (Eds.), The Human Embryonic Stem Cell Debate. Science, Ethics, and Public Policy (pp. 113–119), MIT Press, Cambridge.Google Scholar
- Friend, T. (2001). ‘Half of Stem Cell Money Could Go to Royalties,’ USA Today, August 13, 2001.Google Scholar
- Hollands, P. (1987). ‘Differentiation and Grafting of Haemopoietic Stem Cells from Early Postimplantation Mouse Embryos,’ Development (suppl.), 99, 1, 69–76.Google Scholar
- Hollands (1991). ‘Embryonic Stem Cell Grafting: The Therapy of the Future?’ Human Reproduction, 6, 1, 79–84.Google Scholar
- National Bioethics Advisory Commission (1999). Ethical Issues in Human Stem Cell Research, National Bioethics Advisory Commission Publications, Rockville, MA. [Online] Available: <http://www.bioethics.gov/reports/past_commissions/nbac_stemcell1.pdf>.
- Okarma, T.B. (2001). Human Embryonic Stem Cells: A Primer on the Technology and Its Medical Applications. S. Holland, S. Lebacqz and L. Zoloth (Eds.), The Human Embryonic Stem Cell Debate. Science, Ethics, and Public Policy (pp. 3–14), MIT Press, Cambridge.Google Scholar
- Wolpe, P.R. & McGee, G. (2001). ‘“Expert Bioethics” as Professional Discourse: The Case of Stem Cells,’in S. Holland, K. Lebacqz and L. Zoloth (Eds.), The Human Embryonic Stem Cell Debate (pp. 185–196), The MIT Press, Cambridge.Google Scholar